AG-67650

N/A

Report date: 2023/04/01 22:49:19

Base Information

Drug NameAG-67650

Drug Alias NameAG-67650

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein

Mechanisms of ActionVascular endothelial growth factor inhibitorsPlatelet-derived growth factor receptor inhibitors

TargetsVascular endothelial growth factorPlatelet-derived growth factor receptor

Therapy Area/IndicationsMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAP Biosciences Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsMacular Degeneration

Inactive IndicationsN/A

ATC CodeN/A